Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial comparing risperidone to placebo for manic episodes in bipolar I disorder has completed, with an update on effectiveness and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bipolar Disorders, Manic Episode | Phase 3 | Status: COMPLETED